IBM's Watson Group invests in Pathway Genomics

IBM's Watson Group said it invested in Pathway Genomics Corporation. No financial terms were disclosed. The investment brings Pathway Genomics’ funding in the past six years to more than $80 million.

North AmericaUSBriefs